Lv11
40 积分 2025-05-13 加入
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
1小时前
待确认
Efficacy of radiation therapy plus targeted therapy with or without immunotherapy for lymph node metastases in hepatocellular carcinoma
2个月前
已完结
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
4个月前
已完结
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study
4个月前
已完结
Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma
4个月前
已完结
PSMA and FDG PET/CT Findings for Differential Diagnosis of Bone Metastasis in a Patient With Synchronous Small-cell Lung Cancer and Prostate Cancer
4个月前
已完结
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
9个月前
已完结
皖公网安备34019202002308
